The microenvironment, including microbial ecosystems, crucially influences the occurrence and development of diseases. The advent of multi-omics data provides unprecedented opportunities to explore the intricate interplay between the microenvironment and diseases. Integrating diverse omics datasets-genomics, transcriptomics, proteomics, and metagenomics-opens new avenues for unraveling disease variants, identifying targets, and elucidating underlying mechanisms. However, the data’s complexity and diversity necessitate more efficient methods for extracting and integrating pivotal information. In this era of rapid technological advancement, particularly with the widespread integration of artificial intelligence (AI) in medicine, new prospects arise for a comprehensive investigation into the relationship between microenvironments and diseases. The application of AI methodologies holds the potential to comprehensively and precisely reveal the microenvironment’s impact on disease initiation and progression. This promises in-depth elucidation of disease mechanisms, target identification, and the application of AI in drug development, fostering innovative breakthroughs in medicine.
This Research Topic focuses on fundamental aspects of the interplay among artificial intelligence (AI), microenvironments, and diseases. The primary goal is to enhance understanding of how microenvironments intricately shape the initiation and progression of diseases. This entails elucidating the mechanisms through which microenvironments impact diseases, refining methodologies for efficiently integrating multi-omics data, identifying new targets, and applying AI in drug development. By delving into these research objectives and leveraging state-of-the-art technologies, our aim is to enhance comprehension of AI's role in elucidating the relationship between microenvironments and diseases, offering innovative perspectives and solutions for future developments in medical research and treatment.
Potential topics include but are not limited to the following:
1) Recent research achievements underscore notable progress in utilizing AI to address current challenges in understanding microenvironment
2) Machine learning algorithms employed in data mining and pattern recognition, along with the deep learning methods applied in analyzing of imaging and omics data, to collectively offer potent and robust tools for comprehending the intricate connection between microenvironments and diseases
3) In-depth investigations into single-cell omics, metagenomics, and multi-omics data, coupled with rapid advancements in data integration techniques to provide a comprehensive understanding of the intricate associations between complex microenvironments and diseases
Keywords:
Artificial Intelligence, Microenvironment, Disease Mechanism, Targets Identification, Drug Development
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The microenvironment, including microbial ecosystems, crucially influences the occurrence and development of diseases. The advent of multi-omics data provides unprecedented opportunities to explore the intricate interplay between the microenvironment and diseases. Integrating diverse omics datasets-genomics, transcriptomics, proteomics, and metagenomics-opens new avenues for unraveling disease variants, identifying targets, and elucidating underlying mechanisms. However, the data’s complexity and diversity necessitate more efficient methods for extracting and integrating pivotal information. In this era of rapid technological advancement, particularly with the widespread integration of artificial intelligence (AI) in medicine, new prospects arise for a comprehensive investigation into the relationship between microenvironments and diseases. The application of AI methodologies holds the potential to comprehensively and precisely reveal the microenvironment’s impact on disease initiation and progression. This promises in-depth elucidation of disease mechanisms, target identification, and the application of AI in drug development, fostering innovative breakthroughs in medicine.
This Research Topic focuses on fundamental aspects of the interplay among artificial intelligence (AI), microenvironments, and diseases. The primary goal is to enhance understanding of how microenvironments intricately shape the initiation and progression of diseases. This entails elucidating the mechanisms through which microenvironments impact diseases, refining methodologies for efficiently integrating multi-omics data, identifying new targets, and applying AI in drug development. By delving into these research objectives and leveraging state-of-the-art technologies, our aim is to enhance comprehension of AI's role in elucidating the relationship between microenvironments and diseases, offering innovative perspectives and solutions for future developments in medical research and treatment.
Potential topics include but are not limited to the following:
1) Recent research achievements underscore notable progress in utilizing AI to address current challenges in understanding microenvironment
2) Machine learning algorithms employed in data mining and pattern recognition, along with the deep learning methods applied in analyzing of imaging and omics data, to collectively offer potent and robust tools for comprehending the intricate connection between microenvironments and diseases
3) In-depth investigations into single-cell omics, metagenomics, and multi-omics data, coupled with rapid advancements in data integration techniques to provide a comprehensive understanding of the intricate associations between complex microenvironments and diseases
Keywords:
Artificial Intelligence, Microenvironment, Disease Mechanism, Targets Identification, Drug Development
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.